Infliximab as ultima ratio in a case of refractory non-Crohn’s disease complex fistula system: case report and mini-review of the literature - Top-Institutions - MDSpire

Infliximab as ultima ratio in a case of refractory non-Crohn’s disease complex fistula system: case report and mini-review of the literature

  • By

  • Nada Agbariah

  • Matthias Kis

  • Christine Manser

  • Luc Biedermann

  • Gerhard Rogler

  • June 16, 2026

  • 0 min

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    our university hospital
    our university hospital

    Unknown City, Unknown State

    Key Differentiators

    • Gastroenterology

  • #2

    NYU Langone Health
    NYU Langone Health

    New York, NY

    Key Differentiators

    • Gastroenterology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology

  • #4

    Hospital Clinic
    Hospital Clinic

    Barcelona, Spain

    Key Differentiators

    • Gastroenterology

  • #5

    Medical University of Vienna
    Medical University of Vienna

    Vienna, Austria

    Key Differentiators

    • Gastroenterology

Original Source(s)

Infliximab as ultima ratio in a case of refractory non-Crohn’s disease complex fistula system: case report and mini-review of the literature

  • by Nada Agbariah, Matthias Kis, Christine Manser, Luc Biedermann, Gerhard Rogler

  • June 16, 2026

Related Content

Casein hydrolysate promotes intestinal repair in adult mice with Salmonella enteritis through a lactate-GPR81-Wnt3A axis in intestinal stem cell niche

Critical shortage of gastrointestinal physician density in the USA: impact on mortality from upper gastrointestinal bleeding

Afferent loop syndrome secondary to recurrent pancreatic adenocarcinoma post-Whipple procedure: case report